Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.96 USD | +0.51% | -12.05% | -29.89% |
05-16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.89% | 364M | |
+62.37% | 62.59B | |
-2.24% | 41.18B | |
+43.96% | 40.29B | |
-8.29% | 27.9B | |
+11.68% | 26.21B | |
-22.06% | 19.09B | |
+4.68% | 13.08B | |
+25.12% | 12.26B | |
+28.03% | 12.05B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Transcript : Replimune Group, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 02